Last updated on May 2020

Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection


Brief description of study

The main purpose of this study is to evaluate the activity of low dose oral selinexor (KPT-330) and to evaluate the clinical recovery, the viral load, length of hospitalization and the rate of morbidity and mortality in participants with severe COVID-19 compared to placebo.

Clinical Study Identifier: NCT04349098

Find a site near you

Start Over

Norton Healthcare

Louisville, KY United States
3.7miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.